February 6, 2018 / 9:26 AM / 16 days ago

India's Lupin Q3 profit down 65 pct, misses estimates

Feb 6 (Reuters) - Lupin Ltd, India’s second-largest drugmaker by revenue, on Tuesday posted a 65 percent fall in third-quarter net profit, well below analysts’ estimates.

Profit came in at 2.22 billion rupees ($34.60 million) for the quarter ended Dec. 31, versus 6.33 billion rupees a year earlier. (bit.ly/2E47T4m)

That compared with an average estimate of 4.21 billion rupees from 19 analysts polled by Thomson Reuters I/B/E/S. ($1 = 64.1550 Indian rupees) (Reporting by Jessica Kuruthukulangara in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below